Manufacturing And Sustainability
-
A Robust, Future-Ready Solution That Adapts To Your Needs
5/22/2025
Explore a future-ready solution that features advanced automation, intuitive design, and scalable solutions to streamline your bioprocessing workflows and prepare your operations for future growth.
-
Fast Track Your Path To Commercialization
5/21/2025
Discover key strategies for scaling biologics from bench to pilot scale and learn how to overcome challenges in process development, including control of agitation, oxygen, CO₂, and nutrient supplementation.
-
A Collaboration With Zurich University Of Applied Sciences
5/19/2025
Explore ZHAW’s pioneering work and collaboration in cell cultivation and bioprocessing to deliver scalable, high-performance solutions that address key challenges in biomanufacturing scale-up.
-
Validation Of A qPCR Assay For Host Cell DNA Quantitation
6/9/2025
Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.
-
Resources For Successful IND Submissions
2/21/2023
In this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, NDA Partners Regulatory Affairs Expert Consultant Daniela Drago, Ph.D. and Umoja Biopharma VP of Regulatory Affairs Helen Kim offer several of their go-to resources for guidance when preparing an IND submission.
-
Analytical Solutions To Help Accelerate Bioprocessing Success
11/1/2024
Unlock the power of data-driven bioprocessing. Discover how advanced analytics can optimize your cell culture process, improve performance, and accelerate success.
-
Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials
1/24/2024
Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.
-
Accelerating mAb Process Development In The Growing Therapeutics Market
8/20/2024
The market for mAbs and mAb variants is growing rapidly. Explore the latest strategies and advancements in early stage mAb up- and downstream process development.
-
Process Liquids And Buffers Offering
5/2/2024
Whether you are a researcher, scientist, or industry professional, this video will provide valuable insights into our large volume liquids manufacturing capabilities.
-
Addressing Post-Translational Modifications In Novel Protein Therapeutics
9/13/2024
Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.